FDA Approvals For Dexamethasone Sodium Phosphate Injection USP, 4 Mg (Base)/mL And Dexamethasone Sodium Phosphate Injection USP, 10 Mg (Base)/mL Akorn-Strides, LLC announced the approval of two ANDAs for Dexamethasone Sodium Phosphate Injection USP, 4 mg (base)/mL in 1mL, 5 mL, and 30 mL vials, and Dexamethasone Sodium Phosphate Injection USP, 10 mg (base)/mL in 10 mL vials. Akorn-Strides, LLC is a Joint Venture that was formed in 2005 by Akorn, Inc. (NASDAQ: AKRX) and Strides Arcolab Limited (NSE: STAR)(BSE: 532531).
Source: www.medicalnewstoday.com
# posted by Network @ 8:00 PM
